TP53 and neuroblastoma: Indeed, the anti-tumor effects of nutlin-3, a cis-imidazoline analogue that selectively disrupts the interaction between TP53 and MDM2 resulting in targeted activation of the TP53 pathway, have extensively been reported in neuroblastoma [7–11].